Department of Neurosurgery, Hospital Universitario Clínico San Carlos, 28040 Madrid, Spain.
J Infect. 2010 Jul;61(1):9-20. doi: 10.1016/j.jinf.2010.03.030. Epub 2010 Apr 2.
Cerebrospinal fluid shunting devices are foreign bodies internally or externally placed in a patient with the aim of improving the prognosis. Device-related infection is the most serious complication. Its importance arises from the high frequency of occurrence and the consequences that it implies in terms of morbidity and mortality. As a result, the presence of these two factors increases significantly hospital costs. Among many primary prevention measures investigated, one of those that has gained in importance over the last years is the use of antibiotic-impregnated catheters. Although their experimental development dates back to the 1970s, experience in clinical practice has not been settled until the last decade. This is the reason why only 22 studies on the usefulness of AICs in CSF shunting procedures in clinical practice have been published in the literature since their commercialization. Although experience with antibiotic-impregnated shunts continues growing, practice with antibiotic-impregnated external ventricular drains is much shorter. The present study reviews and analyses the different investigations performed in order to determine the efficacy of antibiotic-impregnated shunts and external ventricular drains with the aim of reducing device-related infectious complications. The results suggest that AICs reduce device-related infection as well as hospital costs. However, evidence is not enough to state categorical conclusions, and further large, prospective, randomized and double-blind studies must be performed in order to confirm these results and the efficacy of other antibiotic-impregnated devices. Further economic evaluation is required to confirm the benefit in terms of cost-effectiveness as well.
脑积水分流装置是指将异物置于患者体内或体外,以改善预后的一种方法。与装置相关的感染是最严重的并发症。其重要性在于其发生频率高,且会导致发病率和死亡率上升。因此,这两个因素的存在大大增加了医院的成本。在众多研究的初级预防措施中,近年来,抗生素浸渍导管的使用越来越受到重视。尽管其在实验开发方面可以追溯到 20 世纪 70 年代,但直到过去十年,其在临床实践中的经验才得以确定。这就是为什么自商业化以来,文献中仅发表了 22 篇关于 AIC 在 CSF 分流术中应用的有用性的研究。尽管抗生素浸渍分流器的经验在不断增加,但抗生素浸渍外部脑室引流的经验要短得多。本研究回顾和分析了为降低与装置相关的感染性并发症而进行的不同研究,以确定抗生素浸渍分流器和外部脑室引流的疗效。结果表明,AIC 可降低与装置相关的感染和医院成本。然而,证据还不足以得出明确的结论,必须进行更多的大型、前瞻性、随机和双盲研究,以证实这些结果以及其他抗生素浸渍装置的疗效。还需要进一步的经济评估来确认成本效益方面的益处。